Biotech · Private company · Irvine, CA, US
Neuraegis, Inc.
Track this companyFree. Adds Neuraegis, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsyFiscal year 2024 · $19.5KNIH RePORTER 3R41NS130825-02S1 · fetched Nov 12, 2026
- Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsyFiscal year 2024 · $197.8KNIH RePORTER 5R41NS130825-02 · fetched Nov 12, 2026